chr18-6243295-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001330559.2(L3MBTL4):c.459G>C(p.Lys153Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,578,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330559.2 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152126Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000213 AC: 49AN: 229912 AF XY: 0.000161 show subpopulations
GnomAD4 exome AF: 0.000102 AC: 146AN: 1426608Hom.: 0 Cov.: 29 AF XY: 0.000109 AC XY: 77AN XY: 707466 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000105 AC: 16AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74294 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.459G>C (p.K153N) alteration is located in exon 7 (coding exon 5) of the L3MBTL4 gene. This alteration results from a G to C substitution at nucleotide position 459, causing the lysine (K) at amino acid position 153 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at